Figure 1.
High parity (≥5 deliveries) before breast cancer diagnosis predicted poor breast cancer-specific survival in the overall cohort (A) and separately in luminal B-like (HER2 negative) breast cancers (B). (C) Shows the long-term breast cancer-specific survival according to the intrinsic subtype immunohistochemical surrogates. TNBC, triple-negative breast cancer.